- Home
- SCNI vs AKAN Comparison
SCNI vs AKAN Comparison
Compare SCNI & AKAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCNI
- AKAN
- Stock Information
- Founded
- SCNI 2003
- AKAN 2021
- Country
- SCNI Israel
- AKAN United Kingdom
- Employees
- SCNI N/A
- AKAN N/A
- Industry
- SCNI Biotechnology: Biological Products (No Diagnostic Substances)
- AKAN Medicinal Chemicals and Botanical Products
- Sector
- SCNI Health Care
- AKAN Health Care
- Exchange
- SCNI Nasdaq
- AKAN Nasdaq
- Market Cap
- SCNI 1.9M
- AKAN 1.7M
- IPO Year
- SCNI N/A
- AKAN 2022
- Fundamental
- Price
- SCNI $2.55
- AKAN $1.15
- Analyst Decision
- SCNI
- AKAN
- Analyst Count
- SCNI 0
- AKAN 0
- Target Price
- SCNI N/A
- AKAN N/A
- AVG Volume (30 Days)
- SCNI 18.0K
- AKAN 33.7K
- Earning Date
- SCNI 05-14-2025
- AKAN 05-09-2025
- Dividend Yield
- SCNI N/A
- AKAN N/A
- EPS Growth
- SCNI N/A
- AKAN N/A
- EPS
- SCNI 8.20
- AKAN N/A
- Revenue
- SCNI $452,000.00
- AKAN $2,508,317.00
- Revenue This Year
- SCNI N/A
- AKAN N/A
- Revenue Next Year
- SCNI N/A
- AKAN N/A
- P/E Ratio
- SCNI $0.30
- AKAN N/A
- Revenue Growth
- SCNI N/A
- AKAN N/A
- 52 Week Low
- SCNI $1.90
- AKAN $0.93
- 52 Week High
- SCNI $8.92
- AKAN $47.52
- Technical
- Relative Strength Index (RSI)
- SCNI 45.49
- AKAN 39.12
- Support Level
- SCNI $1.90
- AKAN $1.08
- Resistance Level
- SCNI $2.54
- AKAN $1.24
- Average True Range (ATR)
- SCNI 0.29
- AKAN 0.10
- MACD
- SCNI 0.04
- AKAN 0.01
- Stochastic Oscillator
- SCNI 47.71
- AKAN 70.97
About SCNI Scinai Immunotherapeutics Ltd.
Scinai Immunotherapeutics Ltd is a biopharmaceutical company focused on developing, manufacturing and commercializing products for the prevention and treatment of infectious diseases and other illnesses. It has executed eight clinical trials in seven countries, around 12,400 participants in the Phase 3 trial of its vaccine candidate and has built a GMP biologics manufacturing facility for biopharmaceutical products. The company is aiming to develop a pipeline of diversified and commercially viable products and platforms beginning with a nanosized antibody (NanoAb) pipeline.
About AKAN Akanda Corp.
Akanda Corp is a cannabis cultivation, manufacturing, and distribution company. The Company has three reportable segments: Cultivation, Distribution, and Corporate. Cultivating activities comprise the cultivation segment made up of the medical cannabis cultivation operations at RPK/Holigen in Portugal, and medical cannabis cultivation activities. Distributing activities relate to the distribution of medical cannabis by Canmart Ltd in the United Kingdom. Corporate activities entail head office costs and other general corporate expenses related to the administration of the broader group.